2,5-Diaryl-1,3,4-oxadiazoles as selective COX-2 inhibitors and anti-inflammatory agents

Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3- c ]pyrazol-4(1 H )-ones as potential cyclooxygenase-2 (COX-2) inhibitors

(2014) Jagdeep Grover et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors

(2014) Jagdeep Grover et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Pyrazolylbenzyltriazoles as cyclooxygenase inhibitors: synthesis and biological evaluation as dual anti-inflammatory and antimicrobial agents

(2014) Nisha Chandna et al.   NEW JOURNAL OF CHEMISTRY

COX-2 Inhibitors and Cardiovascular Risk

(2012) C. P. Cannon et al.   SCIENCE

Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction

(2011) Anne-Marie Schjerning Olsen et al.   CIRCULATION

Oxadiazoles in Medicinal Chemistry

(2011) Jonas Boström et al.   JOURNAL OF MEDICINAL CHEMISTRY

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

(2011) Juan F. Navarro-González et al.   Nature Reviews Nephrology

N-Chlorosuccinimide/1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU)–Mediated Synthesis of 2,5-Disubstituted 1,3,4-Oxadiazoles

(2010) Santosh P. Pardeshi et al.   SYNTHETIC COMMUNICATIONS

COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex

(2008) Klaus Höcherl et al.   KIDNEY INTERNATIONAL

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE